ArticleEuropean radiology2019
Multiparametric ultrasomics of significant liver fibrosis: A machine learning-based analysis.
Article in European radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
72 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Role of radiomics in staging liver fibrosis: a meta-analysis.BMC medical imaging · 2024Pooled it
- Liver fibrosis classification from ultrasound using machine learning: a systematic literature review.Abdominal radiology (New York) · 2024Pooled it
- Diagnosis of Liver Fibrosis Using Artificial Intelligence: A Systematic Review.Medicina (Kaunas, Lithuania) · 2023Pooled it
- Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis.BMC gastroenterology · 2021Pooled it
- Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics.European journal of nuclear medicine and molecular imaging · 2019Pooled it
- Deep learning for precision grading of Schistosoma japonicum-induced liver fibrosis in ultrasound images.Nature communications · 2026Article
- [Application and prospects of artificial intelligence from tool empowerment to paradigm reconstruction for whole-course diagnosis and treatment of liver diseases by ultrasound].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026Review
- Development of a hybrid deep learning-based framework for liver fibrosis classification using ultrasound images.iLIVER · 2026Article
- Early Detection of Liver Fibrosis Using Scatteromics Based on Multimodal QUS Envelope Statistics Imaging.Diagnostics (Basel, Switzerland) · 2026Article
- Harnessing artificial intelligence for the assessment of liver fibrosis and steatosisWorld journal of gastroenterology · 2026Review
- Advancements in artificial intelligence applications for liver ultrasound imaging.BJR artificial intelligence · 2026Review
- Radiomics with Ultrasound Radiofrequency Data for Improving Evaluation of Duchenne Muscular Dystrophy.Journal of imaging informatics in medicine · 2025Article
- Meta-Analysis of AI Integration in Abdominal Imaging for Liver Fibrosis and MASLD: Evaluating Diagnostic Accuracy and Clinical Impact.Journal of clinical medicine · 2025Review
- A Novel Deep Learning Framework for Liver Fibrosis Staging and Etiology Diagnosis Using Integrated Liver-Spleen Elastography.Diagnostics (Basel, Switzerland) · 2025Article
- Machine-learning model based on ultrasomics for non-invasive evaluation of fibrosis in IgA nephropathy.European radiology · 2025Article
- Vasomics of the liver.Gut · 2025Review
- Ultrasound radiomics-based logistic regression model for fibrotic NASH.BMC gastroenterology · 2025Article
- Bayesian Optimization-Enhanced Machine Learning for Osteosarcoma Risk Stratification Based on Sphingolipid Metabolism.Human mutation · 2025Article
- Analyses of gingival papilla blood flow via color doppler flow imaging and micro-flow imaging in patients with advanced periodontitis: a clinical pilot study.European journal of medical research · 2024Article
- Super-resolution ultrasound and microvasculomics: a consensus statement.European radiology · 2024Review
12 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
objectiveTo assess significant liver fibrosis by multiparametric ultrasomics data using machine learning. MATERIALS AND
methodsThis prospective study consisted of 144 patients with chronic hepatitis B. Ultrasomics-high-throughput quantitative data from ultrasound imaging of liver fibrosis-were generated using conventional radiomics, original radiofrequency (ORF) and contrast-enhanced micro-flow (CEMF) features. Three categories of features were explored using pairwise correlation and hierarchical clustering. Features were selected using diagnostic tests for fibrosis, activity and steatosis stage, with the histopathological results as the reference. The fibrosis staging performance of ultrasomics models with combinations of the selected features was evaluated with machine-learning algorithms by calculating the area under the receiver-operator characteristic curve (AUC).
resultsORF and CEMF features had better predictive power than conventional radiomics for liver fibrosis stage (both p < 0.01). CEMF features exhibited the highest diagnostic value for activity stage (both p < 0.05), and ORF had the best diagnostic value for steatosis stage (both p < 0.01). The machine-learning classifiers of adaptive boosting, random forest and support vector machine were found to be optimal algorithms with better (all mean AUCs = 0.85) and more stable performance (coefficient of variation = 0.01-0.02) for fibrosis staging than decision tree, logistic regression and neural network (mean AUC = 0.61-0.72, CV = 0.07-0.08). The multiparametric ultrasomics model achieved much better performance (mean AUC values of 0.78-0.85) than the features from a single modality in discriminating significant fibrosis (≥ F2).
conclusionMachine-learning-based analysis of multiparametric ultrasomics can help improve the discrimination of significant fibrosis compared with mono or dual modalities. KEY POINTS: • Multiparametric ultrasomics has achieved much better performance in the discrimination of significant fibrosis (≥ F2) than the single modality of conventional radiomics, original radiofrequency and contrast-enhanced micro-flow. • Adaptive boosting, random forest and support vector machine are the optimal algorithms for machine learning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.